Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Regulatory News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Regulatory News
 
CFDA and NHFPC Announce List of Approved Stem Cell Clinical Resea... 10/31/2016
CDE Solicits Comments on Technical Guidelines for Extrapolation o... 10/31/2016
CDE Publicizes List of Drug Applications To Be Granted Priority R... 10/31/2016
CFDA Hears Opinions of Local Pharma Companies on Drug Registratio... 10/30/2016
CFDA and SASTIND Issue Notice on Renewal of Radioactive Drug Manu... 10/26/2016
CMBA Releases Self-Discipline Guideline for Quality Control of St... 10/25/2016
NHFPC Issues the Rules for Ethical Review of Biomedical Research ... 10/24/2016
The Pharmacopoeia Commission of China Solicits Public Comments on... 10/24/2016
CFDA Drug Registration Official Interviewed Over New Drug Clinica... 10/24/2016
CFDI to Initiate Onsite Clinical Data Inspections of Another 50 D... 10/23/2016
CFDA Solicits Public Comments on Biochemical Drug Appendix of GMP... 10/19/2016
CFDA Solicits Public Comments on Three Appendices of GSP 10/18/2016
CFDA Solicits Public Comments on Cleanup of Past Official Documen... 10/18/2016
Drug Registration Approval and Application Update Q3/2016 10/12/2016
CFDA Issues Draft Guidelines for Drug Data Management for Public ... 10/11/2016
CDE Releases Draft Guideline for Phase I Clinical Trial Applicati... 10/3/2016
CFDA Issues Policy for Tracing of Food and Drug Products 9/28/2016
28 Central Government Agencies Sign MOU for Joint Punishment of S... 9/22/2016
CFDA Solicits Public Comments on Draft Rules on Imported Herbal C... 9/20/2016
CFDA Seeks Comments on New Review Guideline for Equivalence Studi... 9/14/2016
CFDA Releases New Announcement for Excessively-Supplied Drug Prod... 9/14/2016
CDE Grants Prioirty Review Status to 17 Drug Registration Applica... 9/14/2016
CDE Seeks Public Comments on 2nd Draft of Rules for Transparency ... 9/9/2016
China Further Heightens Regulation of Medical and Drug Ads 9/8/2016
China Urged to Reconsider Approval of GSL's HPV Vaccine Cervarix 9/5/2016
CFDA Issues Announcement for Registration Fees of Chemical Drugs ... 9/2/2016
CFDA Issues Another Announcement (2016#142) for Clinical Data Sel... 9/1/2016
CFDA Suspends Import of Lab Farmacerutico CTSRL’s Gluthion 8/30/2016
CFDA Solicits Comments for Announcement over Drug Clinical Trial ... 8/26/2016
CFDA Terminates Import of LLM’s Difrarel Tablets for Unreported ... 8/25/2016
Page:6/7    Total number of articles:196  :[<<][6][7][First]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links